Molecules of Korolchuk IP-NFT (VITA-FAST)

Overview

Molecules of Korolchuk IP-NFT (VITA-FAST) market snapshot: Price $0.457620, market capitalization $457.62K, and reported 24-hour volume $5.

Trading activity: Reported 24-hour volume equals 0.00% of market capitalization. The local markets snapshot lists Uniswap V4 (Ethereum) and Uniswap V3 (Ethereum) among venues with observed trading activity.

YearBull indicators: YearBull Rank #6,545. Bull Score 38/100. YB Market Risk Low. This relative market-volatility label is not an investment-safety assessment. Cycle Early. Observed price change: 24h 0.00% · 7d -7.68% · 30d -33.29%.

Values are descriptive and should be read together rather than as a price forecast. Read the YearBull methodology. Snapshot date: 2026-10-27. Data history: 90 days available in the latest 90-day window.

Methodology responsibility: YearBull’s analytical methodology and presentation rules are developed and maintained by Alan Zelvin, Founder & Lead Crypto Researcher. This note identifies responsibility for the methodology; it does not attribute authorship of this data snapshot.

What is Molecules of Korolchuk IP-NFT (VITA-FAST)?

Source description

“What is the project about? VitaDAO, a decentralized autonomous organization, introduces VITA-FAST, an innovative funding model for longevity research. Leveraging the Ethereum blockchain, VITA-FAST are ERC-20 tokens, signifying fractional ownership of the Intellectual Property Non-Fungible Token (IP-NFT) from longevity research conducted at the Korolchuk Lab, Newcastle University. VITA-FAST token holders gain governance rights over the IP, democratizing the decision-making processes in scientific research. 1. What is the project about? The project is focused on discovering and developing therapeutic compounds that can reactivate autophagy in Npc1 -/- cells. This involves screening bioactive and commercial small molecules in cell survival assays to identify potential autophagy activators that are not cytotoxic. The project uses advanced techniques like luciferase-p6 clearance and Halo-GFP-LC3 orthogonal assays for this purpose. 2. What makes your project unique? The project's uniqueness lies in its approach to identifying novel compounds that can induce autophagy in NPC1 -/- cells, a crucial process for treating Niemann-Pick Type C disease. Unlike existing treatments, this project employs high-throughput screening methods and innovative assays to discover compounds with high chemical variability and no similarity to existing autophagy inducers, opening up possibilities for new iIP. 3. History of your project. The project, led by Dr. Korolchuk and his team at Newcastle University, has progressed from generating data on thousands of compounds using advanced screening assays to identifying lead compounds with potential autophagic properties.”

This source-supplied description may contain old, promotional, or unverified claims and is not YearBull editorial analysis.

Molecules of Korolchuk IP-NFT (VITA-FAST) project facts

Official links and contract records appear in Key Facts. Project details can change, so verify current information with the project.

Molecules of Korolchuk IP-NFT (VITA-FAST) FAQ

How does VITA-FAST relate to the Korolchuk Lab’s research intellectual property?

The project describes VITA-FAST as ERC-20 tokens representing fractional ownership of an Intellectual Property Non-Fungible Token linked to longevity research conducted at the Korolchuk Lab at Newcastle University. It presents this structure as a way for token holders to participate in governance relating to the underlying intellectual property and to broaden involvement in scientific decision-making.

What biological process is the research trying to activate in NPC1-deficient cells?

The research focuses on identifying therapeutic compounds that may reactivate autophagy in Npc1 -/- cells. Autophagy is a cellular recycling process, and the project connects its investigation to potential treatments for Niemann-Pick Type C disease. The stated screening objective is to find compounds that improve cell survival without causing cytotoxic effects.

Which screening methods are being used to evaluate possible autophagy activators?

The project states that it screens bioactive and commercial small molecules through cell-survival assays, supported by luciferase-p6 clearance and Halo-GFP-LC3 orthogonal assays. Using more than one assay is presented as a way to assess autophagy-related activity from different experimental angles while looking for compounds that are not harmful to the tested cells.

What does the project claim is distinctive about its compound-discovery approach?

The project presents its approach as a high-throughput search for compounds that can induce autophagy in NPC1-deficient cells while showing substantial chemical variability and no similarity to existing autophagy inducers. It describes this strategy as a route toward discovering novel compounds and developing intellectual property distinct from previously known autophagy-activating molecules.

Molecules of Korolchuk IP-NFT metric comparison

This comparison is a stored snapshot generated 2026-10-23 06:30 UTC from 292 daily observations available from 2025-12-30 through 2026-10-23. It is separate from the latest analytical cards above. Percentiles compare the snapshot value with that day's analytical universe; a higher percentile means a larger observed value, not necessarily a better investment characteristic.

MetricSnapshot30d before90d beforeChange vs 30dUniverse percentile
Price$0.4985$0.6112$0.6307-18.4%n/a
Market cap$498.5K$611.2K$630.7K-18.4%P57.4
YearBull Rank#4,488#4,768#4,718Improved 280P47.5
Bull Score50/10044/10033/100+6.0 ptsP49.8
Turnover0.01%0.02%0.30%0.0 ptsP8.2
YB Market RiskLowLowLowUnchangedn/a
CycleEarlyEarlyMidUnchangedn/a

Median absolute daily movement 3.08%; distance from the highest local daily price -80.9%; circulating supply change 0.0%. These measurements are descriptive and do not predict future direction.

YearBull Rank update

YearBull Rank now for molecules-of-korolchuk-ip-nft: #6545.

Rank timeline (last 365 days)

Rank movement (time windows).

Reading rule: lower is better in this ranking.

  • 7d window (2026-10-22): #4433 → #6545 (down by 2112).
  • 30d window (2026-09-28): #3767 → #6545 (down by 2778).

Liquidity posture: a steadier line can indicate steadier access. If the curve improves but won’t hold, treat it as flow-driven.

Cycle note: phase changes usually leave a footprint in consistency. If both are flat, the coin may be tracking its peer basket.

Risk profile: minor drift can still matter at scale. If the curve whipsaws, treat the rank as fragile.

Access context: fragmentation can make rank more reactive. If rank improves slowly, it often reflects broader access or steadier participation.

YearBull Rank is an internal ordering on YearBull that positions a coin relative to the rest of the tracked universe. A smaller rank number indicates a stronger position at that moment. Use it as positioning context over time, not as a promise.

Editorial note: This analysis was prepared by the YearBull research team under the direction of Alan Zelvin, Founder and Lead Crypto Researcher. The assessment follows YearBull’s internal research methodology and editorial standards. Methodology · Editorial Policy
Research context

Related research and comparable assets

All hubs →

Similar coins

Skeb (SKEB) (SKEB) logoSkeb (SKEB)SKEB$0.00004743#7,002
XONA AGENT (XONA) logoXONA AGENTXONA$0.00047355#5,252
Stockereum.fun (STOCKER) logoStockereum.funSTOCKER$0.00045694#8,747

Popular by YearBull Rank

Molecules of Korolchuk IP-NFT (VITA-FAST) Markets

Stored venue snapshot. Markets last checked: 2026-07-26. Updated on a rolling basis; no fixed refresh date is promised. Venue listings and volumes are stored snapshots, not live quotes.
Exchange Top Pair Stored 24h volume (snapshot) Trust Rank
Uniswap V4 (Ethereum) VITA-FAST/BIO $62 #173
Uniswap V3 (Ethereum) VITA-FAST/VITA $61 #175

Listings are ordered by reported snapshot volume. Trust Rank is an external venue-quality indicator; it is not an endorsement or a solvency guarantee.